Comprehensive immune monitoring reveals profound immunological changes in pancreas after kidney (PAK) transplant recipients

Human Immunology

Volumn 74, Issue 6, 2013, Pages 738-745

  Kudva, Yogish C ^a   Erickson, Jenna R ^a   Parsaik, Ajay ^a   Rostambeigi, Nassir ^b   Thapa, Prabin ^a   Abraham, Roshini S ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; B LYMPHOCYTE; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MALE; PANCREAS AFTER KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; ANTIBODY FORMATION; B-LYMPHOCYTES; CYTOKINES; FEMALE; HUMANS; IMMUNOPHENOTYPING; KIDNEY TRANSPLANTATION; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MITOGENS; MONITORING, IMMUNOLOGIC; PANCREAS; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 84877061939     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2013.02.004     Document Type: Article

References (43)

1. Fridell J.A., Mangus R.S., Hollinger E.F., Taber T.E., Goble M.L., Mohler E., et al. The case for pancreas after kidney transplantation. Clin Transplant 2009, 23:447.
2. Gruessner A.C., Sutherland D.E. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004. Clin Transplant 2005, 19:433.
3. Venstrom J.M., McBride M.A., Rother K.I., Hirshberg B., Orchard T.J., Harlan D.M. Survival after pancreas transplantation in patients with diabetes and preserved kidney function. JAMA 2003, 290:2817.
4. Drachenberg C.B., Odorico J., Demetris A.J., Arend L., Bajema I.M., Bruijn J.A., et al. Banff schema for grading pancreas allograft rejection: working proposal by a multi-disciplinary international consensus panel. Am J Transplant 2008, 8:1237.
5. Esposito L., Kamar N., Tkaczuk J., Abbal M., Durand D., Rostaing L. Long-term evolution of lymphocytes subsets after induction therapy based on continuous versus discontinuous administration of anti-thymocyte globulins in renal-transplant patients. Transplant Proc 2005, 37:785.
6. Klaus G., Mostert K., Reckzeh B., Mueller T.F. Phenotypic changes in lymphocyte subpopulations in pediatric renal-transplant patients after T-cell depletion. Transplantation 2003, 76:1719.
7. Muller T.F. Long-term T cell dynamics following the use of polyclonal and monoclonal antibodies. Graft 1999, 2:S15.
8. Muller T.F., Grebe S.O., Neumann M.C., Heymanns J., Radsak K., Sprenger H., et al. Persistent long-term changes in lymphocyte subsets induced by polyclonal antibodies. Transplantation 1997, 64:1432.
9. Ona E.T., Danguilan R.A., Africa J., Cabanayan-Casasola C.B., Antonio Z.L., Gutierrez-Marbella M.A., et al. Use of alemtuzumab (Campath-1H) as induction therapy in pediatric kidney transplantation. Transplant Proc 2008, 40:2226.
10. Rondelli D., Abbasian J., Arpinati M., Panaro F., Porubsky M., Manzelli A., et al. Different reconstitution of peripheral blood lymphocytes and dendritic cells in liver and kidney transplant patients. Transplant Proc 2005, 37:49.
11. Toso C., Edgar R., Pawlick R., Emamaullee J., Merani S., Dinyari P., et al. Effect of different induction strategies on effector, regulatory and memory lymphocyte sub-populations in clinical islet transplantation. Transpl Int 2009, 22:182.
12. Zand M.S. Immunosuppression and immune monitoring after renal transplantation. Semin Dial 2005, 18:511.
13. Venkataramanan R., Shaw L.M., Sarkozi L., Mullins R., Pirsch J., MacFarlane G., et al. Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients. J Clin Pharmacol 2001, 41:542.
14. Salic A., Mitchison T.J. A chemical method for fast and sensitive detection of DNA synthesis in vivo. Proc Natl Acad Sci USA 2008, 105:2415.
15. Najera O., Gonzalez C., Toledo G., Lopez L., Cortes E., Betancourt M., et al. CD45RA and CD45RO isoforms in infected malnourished and infected well-nourished children. Clin Exp Immunol 2001, 126:461.
16. Guillonneau C., Picarda E., Anegon I. CD8+ regulatory T cells in solid organ transplantation. Curr Opin Organ Transplant 2010, 15:751.
17. Issa F., Wood K.J. CD4+ regulatory T cells in solid organ transplantation. Curr Opin Organ Transplant 2010, 15:757.
18. Ming C.-S., Chen Z.-H.K. Progress in pancreas transplantation and combined pancreas-kidney transplantation. Hepatobiliary Pancreat Dis Int 2007, 6:17.
19. Gruessner R.W. Immunosuppression after pancreas transplantation. Transplant Proc 2005, 37:1663.
20. Axelrod D., Kaufman D.B. Novel immunosuppression in pancreas transplantation and outcomes. Curr Opin Organ Transplant 2007, 12:77.
21. Lopez M., Clarkson M.R., Albin M., Sayegh M.H., Najafian N. A novel mechanism of action for anti-thymocyte globulin: induction of CD4+CD25+Foxp3+ regulatory T cells. J Am Soc Nephrol 2006, 17:2844.
22. Mohty M. Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond. Leukemia 2007, 21:1387.
23. Djamali A., Turc-Baron C., Portales P., Leverson G., Chong G., Clot J., et al. Low dose antithymocyte globulins in renal transplantation: daily versus intermittent administration based on T-cell monitoring. Transplantation 2000, 69:799.
24. Krasinskas A.M., Kreisel D., Acker M.A., Bavaria J.E., Pochettino A., Kotloff R.M., et al. CD3 monitoring of antithymocyte globulin therapy in thoracic organ transplantation. Transplantation 2002, 73:1339.
25. Uber W.E., Uber L.A., VanBakel A.B., Crumbley A.J., Pereira N.L., Ikonomidis J.S., et al. CD3 monitoring and thymoglobulin therapy in cardiac transplantation: clinical outcomes and pharmacoeconomic implications. Transplant Proc 2004, 36:3245.
26. Gurkan S., Luan Y., Dhillon N., Allam S.R., Montague T., Bromberg J.S., et al. Immune reconstitution following rabbit antithymocyte globulin. Am J Transplant 2010, 10:2132.
27. Douek D.C., Vescio R.A., Betts M.R., Brenchley J.M., Hill B.J., Zhang L., et al. Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution. Lancet 2000, 355:1875.
28. Hazenberg M.D., Verschuren M.C., Hamann D., Miedema F., van Dongen J.J. T cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation. J Mol Med 2001, 79:631.
29. Kimmig S., Przybylski G.K., Schmidt C.A., Laurisch K., Mowes B., Radbruch A., et al. Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood. J Exp Med 2002, 195:789.
30. Yu Y., Arora A., Min W., Roifman C.M., Grunebaum E. Edu-Click iT flow cytometry assay as an alternative to [3H]-thymidine for measuring proliferation of human and mice T lymphocytes. J Allergy Clin Immunol 2009, 123:S87.
31. Last'ovicka J., Budinsky V., Spisek R., Bartunkova J. Assessment of lymphocyte proliferation: CFSE kills dividing cells and modulates expression of activation markers. Cell Immunol 2009, 256:79.
32. Chilson O.P., Boylston A.W., Crumpton M.J. Phaseolus vulgaris phytohaemagglutinin (PHA) binds to the human T lymphocyte antigen receptor. EMBO J 1984, 3:3239.
33. Tsien R.Y., Pozzan T., Rink T.J. T-cell mitogens cause early changes in cytoplasmic free Ca2+ and membrane potential in lymphocytes. Nature 1982, 295:68.
34. Ceuppens J.L., Baroja M.L., Lorre K., Van Damme J., Billiau A. Human T cell activation with phytohemagglutinin. The function of IL-6 as an accessory signal. J Immunol 1988, 141:3868.
35. Cicinnati V.R., Hou J., Lindemann M., Horn P.A., Sotiropoulos G.C., Paul A., et al. Mycophenolic acid impedes the antigen presenting and lymph node homing capacities of human blood myeloid dendritic cells. Transplantation 2009, 88:504.
36. Mezger M., Wozniok I., Blockhaus C., Kurzai O., Hebart H., Einsele H., et al. Impact of mycophenolic acid on the functionality of human polymorphonuclear neutrophils and dendritic cells during interaction with Aspergillus fumigatus. Antimicrob Agents Chemother 2008, 52:2644.
37. Sharon N., Lis H. History of lectins: from hemagglutinins to biological recognition molecules. Glycobiology 2004, 14:53R.
38. Stone K.D., Feldman H.A., Huisman C., Howlett C., Jabara H.H., Bonilla F.A. Analysis of in vitro lymphocyte proliferation as a screening tool for cellular immunodeficiency. Clin Immunol 2009, 131:41.
39. Corales R., Chua J., Mawhorter S., Young J.B., Starling R., Tomford J.W., et al. Significant post-transplant hypogammaglobulinemia in six heart transplant recipients: an emerging clinical phenomenon?. Transpl Infect Dis 2000, 2:133.
40. Goldfarb N.S., Avery R.K., Goormastic M., Mehta A.C., Schilz R., Smedira N., et al. Hypogammaglobulinemia in lung transplant recipients. Transplantation 2001, 71:242.
41. Yamani M.H., Avery R.K., Mawhorter S.D., Young J.B., Ratliff N.B., Hobbs R.E., et al. Hypogammaglobulinemia following cardiac transplantation: a link between rejection and infection. J Heart Lung Transplant 2001, 20:425.
42. Schroppel B., Heeger P.S. Gazing into a crystal ball to predict kidney transplant outcome. J Clin Invest 2010, 120:1803.
43. Volk H.D., Zuckermann H., Kox W., Woicieczowsky C.H., Hoeflich C., Buhl K., et al. Immune monitoring and strategies for immune modulation. Molecular and cellular biology of critical care medicine, immunology and infectious disease 2002, Kluwer Academic Publishers. P. Linden, L.A. Doughty (Eds.).